Novocardio
About:
Novocardio is a high-tech company specializing in the genetic diagnosis of cardiovascular diseases.
Website: http://novocardio.com/
Top Investors: Amphora Capital
Description:
Novocardio is a high-tech company specializing in the genetic diagnosis of cardiovascular diseases, providing the leading single gene genetic testing and cardiovascular drug genetic testing services.
Total Funding Amount:
10M CNY
Headquarters Location:
Beijing, Beijing, China
Founded Date:
2016-12-07
Founders:
Wenfeng Li
Number of Employees:
11-50
Last Funding Date:
2020-01-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai